Showing 311-320 of 19172 results for "".
Rethinking Diabetes Care: Key Data from Incorporating Lifestyle Modifications
https://reachmd.com/programs/medical-industry-feature/rethinking-diabetes-care-key-data-from-incorporating-lifestyle-modifications/14289/What role do lifestyle modifications have in managing obesity and type 2 diabetes? Find out.Balancing Blood Sugar: The Role of Yoga in Diabetes Management
https://reachmd.com/programs/what-your-patients-are-talking-about/tbd/15490/Tune in to find out how yoga can help lower blood sugar levels in patients with type 2 diabetes.Obesity, Diabetes and the Metabolic Syndrome
https://reachmd.com/programs/lipid-luminations/obesity-diabetes-and-the-metabolic-syndrome/6706/Host Dr. Alan S. Brown is joined by Kevin C. Maki, PhD, FNLA, Chief Science Officer of Biofortis Clinical Research. Dr. Maki will review obesity, metabolic syndrome and type 2 diabetes mellitus as they are all insulin resistant states and are often characterized by atherogenic dyslipidemia or theThe Diabetes Infrastructure: Regulation & Reimbursement
https://reachmd.com/programs/diabetes-discourse/the-diabetes-infrastructure-regulation-reimbursement/4796/The prevalence of diabetes complications and its associated costs represent an infrastructure that may be virtually unsustainable in the near future. Join host Dr. Steven Edelman and his guest, editor-in-chief of the diabetes publications Closer Look and Diabetes Close Up, Kelly Close, as they discuCurrent Trends and Treatment Goals for Diabetes
https://reachmd.com/programs/focus-on-pharmacy/current-trends-and-treatment-goals-for-diabetes/3531/How can we best optimize pharmacotherapy for patients with Type 2 diabetes? What are the main treatment barriers to keep in mind, and what are the most common comorbidities that we might be able to treat concurrently with diabetes therapy? Dr. Susan Cornell, assistant professor of pharmacy practiceDiagnosing and Tracking the Progression of MacTel Type 2
https://reachmd.com/programs/cme/Diagnosing-and-Tracking-the-Progression-of-MacTel-Type-2/35964/Catch up on the latest information on the management of macular telangiectasia type 2 (MacTel) with a new encapsulated cell therapy, revakinagene taroretcel.What Type 2 Inflammation in COPD Means for Treatment Decision Making
https://reachmd.com/programs/deep-breaths-updates-chest/type-2-inflammation-copd-treatment-decisions/36159/COPD is increasingly recognized as a heterogeneous disease, and for a subset of patients, type 2 inflammation plays a meaningful role in exacerbation risk and treatment response. Given that, Drs. Stephanie Christenson and Diego Maselli come together to examine how insights into the pathobiology of tThe Link Between Diabetes and Sleep Apnea
https://reachmd.com/programs/diabetes-discourse/the-link-between-diabetes-and-sleep-apnea/4601/Type 2 diabetes and obstructive sleep apnea have been shown to have a close relationship. Join host Dr. Steven Edelman and his guest, sleep specialist and pulmonologist Dr. Shazia Jamil, as they discuss the diagnosis and treatments of obstructive sleep apnea including continuous positive airway presDo Women With Diabetes Have a Greater Risk of Cardiovascular Disease?
https://reachmd.com/programs/diabetes-discourse/do-women-with-diabetes-have-a-greater-risk-of-cardiovascular-disease/5946/What is known about the relationship between glucose control and cardiovascular disease in diabetes? The recent Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial provides some interesting results on the relationship between type 2 diabetes and silent mDiabetic Sector Update
https://reachmd.com/programs/clinicians-roundtable/diabetic-sector-update/1643/Join host Larry Kaskel interview David Kliff, a diabetic himself and the publisher of the Diabetic Investor. Learn from David Kliff about the current and future medications and devices in the diabetic market.